BioSpace News Archive

BioCapital

Senseonics Publishes Positive Longitudinal Performance Over Multiple Sensor Insertions and Removal Cycles of the Eversense® CGM System

This real-world data of 945 adult users in the home-setting demonstrated that the performance of the sensor over four sensor cycles is stable and does not decrease over time.

November 21, 2019
·
5 min read
Lone Star Bio

CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option

The additional shares were sold at the IPO price of $4.00 per share, before underwriting discounts and commissions.

November 21, 2019
·
2 min read
Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters

At the Company’s 2019 Annual General Meeting held November 5, 2019, shareholders voted in favor of all proposals contained in the Company’s proxy statement dated October 3, 2019

November 21, 2019
·
8 min read
Azeria Therapeutics Announces £32.0 million Series B Financing

Azeria Therapeutics (Azeria), a newly formed pioneer factor drug discovery company, today announced a £32 million Series B financing in which Syncona has committed £29.5 million alongside existing investor the CRT Pioneer Fund.

November 21, 2019
·
5 min read
FDA

FDA Approves XCOPRI® (cenobamate tablets), an Anti-Epileptic Drug (AED) from SK Biopharmaceuticals, Co., Ltd., and U.S. Subsidiary SK Life Science, Inc.

XCOPRI is approved for the treatment of partial-onset seizures in adult patients

November 21, 2019
·
12 min read
Business

Novomer Announces Appointment of Jeff Uhrig As Chief Executive Officer

New CEO Brings Finance and Chemical Industry Experience to Leadership Post

November 21, 2019
·
2 min read
Business

Patterson Companies Second-Quarter Fiscal 2020 Conference Call Scheduled for Thursday, December 5, 2019

The company’s earnings release will be issued that morning before the market opens.

November 21, 2019
·
1 min read
Mass Photometry: revolutionary biotech by Refeyn Ltd. wins prestigious awards

The company’s proprietary technology can be applied broadly in life sciences research, drug development and biologics quality control.

November 21, 2019
·
1 min read
Bio NC

Spencer Health Solution’s Breakthrough Direct-to-Patient Technology Achieves 97% Medication Adherence

New standard for medication adherence and engagement emerges with growing number of patients using spencer® to manage health at home

November 21, 2019
·
2 min read
Business

Willow Biosciences Reports Third Quarter 2019 Results and Provides Operations Update

Willow Biosciences Inc. has released its financial and operating results for the three and nine months ended September 30, 2019.

November 21, 2019
·
9 min read